Skip to main content
. 2021 Dec 2;13(12):2065. doi: 10.3390/pharmaceutics13122065
BBB Blood–brain barrier
CPP Cell penetrating peptide
DOX Doxorubicin
EGFR Epidermal growth factor receptor
EGFRvIII Epidermal growth factor receptor mutation variant III
FDA Food and Drug Administration
FTC 2’,3’-dideoxy-5-fluoro-3’-thiacytidine (Emtricitabine)
GFP Green Fluorescent Protein
HIV-1 Human immunodeficiency virus type I
HPLC High-performance liquid chromatography
LS Liposomes
MMAE Monomethyl auristatin E
nAchRs Nicotine acetylcholine receptors
NRP-1 Neuropilin-1 receptor
PEG Polyethylene glycol
PMO Phosphorodiamidate morpholino oligonucleotide
QD Quantum dot
RCM Ring-closing metathesis
RE Retro-enantio
siRNA Small interfering RNA
TAM Tumor-associated macrophages
TfR1 Transferrin receptor
VEGFR2 Vascular endothelial growth factor receptor 2